Position in DHR
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$154,860
-$2,128 QoQ
Shares Held
813
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,790
of 2,098 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $764,974 across 5 Diagnostics & Research names. DHR ranks #2 (20.2% of the industry book) .
All Filings in DHR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,860 | 813 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $156,988 | 828 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $192,750 | 842 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $167,926 | 847 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $182,329 | 923 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $198,850 | 970 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $310,581 | 1,353 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $399,792 | 1,438 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $370,027 | 1,481 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $360,595 | 1,444 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $314,852 | 1,361 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $328,484 | 1,324 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $299,520 | 1,248 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $31,504 | 125 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $19,641 | 74 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,914 | 50 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,859 | 31 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $9,093 | 31 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||